GATC Biotech AG is investing more than 5 million euros in its Constance site to double the company's floor space
The mayor Claus Boldt, together with architect Hans-Peter Engelmann and CEO Peter Pohl, officially turned the first sod, thus marking the beginning of the expansion the Constance site of GATC Biotech. The company will invest more than 5 million euros in its Constance headquarters until 2012 to create offices and laboratories for an additional 100 employees.
An extra 960 square meters will more than double the existing laboratory and office space. The three-storey annex will be directly attached to the original building. A glass atrium will connect the old and the new buildings. The architect's office Giel & Engelmann in Constance is responsible for planning and construction supervision.
"Because of our company's strong growth over the last few years, we are in dire need of a new building. We are literally bursting at the seams as we have more than doubled the number of our employees since 2006. Furthermore, we urgently need further laboratory space in order to expand our sequencing capacity to 30 terabases until 2013. This increase in capacity is required to enable us to advance our international expansion plans. We are very proud that we are able to create and secure jobs even in economically difficult times and to strengthen and further expand the dynamic life science hub at Lake Constance," says Peter Pohl.
The inauguration of the annex in spring 2010 will coincide with GATC’s 20th anniversary.
Other news from the department business & finance
These products might interest you
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
